Media Room

/assets/dotcom/content-app/events/banner-investors-events_20230703194346.jpg

Fourth Quarter and Full Year 2024 Results

Fourth quarter and full year 2024 results were reviewed by management during a live audio webcast with the financial community on January 30, 2025. The presentation was followed by a Q&A session.  

Thursday January 30, 2025
15:00 - 16:30 CET (9:00am – 10:30am EST)

Press releases


March 8, 2025
Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD

March 5, 2025
Press release: Sanofi successfully prices EUR 1.5 billion of bond issue

February 28, 2025
Media Update: AAD: new data advance Sanofi’s scientific leadership across innovative treatments for inflammatory skin diseases

Contact Our Media Team

You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.

Publications

Sustainability Statement 2024 (ESG Report)
Download PDF
XBRL Viewer URD 2024
Download PDF
Registration Document 2024 (in French)
Download PDF
XBRL Viewer 20F 2024
Download PDF